These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8084443)

  • 1. GIP and DIP: a new view of uraemic toxicity.
    Haag-Weber M; Mai B; Cohen G; Hörl WH
    Nephrol Dial Transplant; 1994; 9(4):346-7. PubMed ID: 8084443
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of a granulocyte inhibitory protein from uraemic patients with homology of beta 2-microglobulin.
    Haag-Weber M; Mai B; Hörl WH
    Nephrol Dial Transplant; 1994; 9(4):382-8. PubMed ID: 8084451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of middle molecular weight fraction in the plasma of patients with uremia using high performance liquid chromatography and thin layer chromatography].
    Kovalishin IaF; Nikolaev VG; Baran EIa; Dudar' IA; Iushko LA
    Vopr Med Khim; 1988; 34(6):23-6. PubMed ID: 3238937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on clinico-chemical correlations in uraemic polyneuritis.
    Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
    [No Abstract]   [Full Text] [Related]  

  • 5. Separation of peptidic inhibitor of erythropoiesis in uremia.
    Saito A; Ogawa H; Chung TG; Hotta T
    Adv Exp Med Biol; 1987; 223():111-4. PubMed ID: 3447424
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 7. Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro--towards a standardized approach for research on uraemia.
    Cohen G; Glorieux G; Thornalley P; Schepers E; Meert N; Jankowski J; Jankowski V; Argiles A; Anderstam B; Brunet P; Cerini C; Dou L; Deppisch R; Marescau B; Massy Z; Perna A; Raupachova J; Rodriguez M; Stegmayr B; Vanholder R; Hörl WH;
    Nephrol Dial Transplant; 2007 Dec; 22(12):3381-90. PubMed ID: 17724037
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of toxic activity of blood in uremia].
    Shumakov VI; Gabriélian NI; Shcherbaneva OI; Dmitriev AA; Mogireva IA
    Ter Arkh; 1980; 52(4):62-4. PubMed ID: 7404340
    [No Abstract]   [Full Text] [Related]  

  • 9. Genesis of the uraemic syndrome: role of uraemic toxins.
    Hörl WH
    Wien Klin Wochenschr; 1998 Aug; 110(15):511-20. PubMed ID: 9782569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of uremia: physiopathology and clinical signs.
    Bergström J
    Contrib Nephrol; 1989; 71():1-9. PubMed ID: 2680257
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical definition of uremia].
    Ringoir S
    Verh K Acad Geneeskd Belg; 1981; 43(2):105-19. PubMed ID: 7314875
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum middle molecules in uremia.
    Buzio C; Manari A; Calderini C; Montagna G; Migone L
    Artif Organs; 1981; 4 Suppl():143-50. PubMed ID: 7295081
    [No Abstract]   [Full Text] [Related]  

  • 13. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of the determination of the blood serum levels of middle molecules for screening azotemia].
    Titel'man KM; Mustafaeva TM; Ianovskaia IK
    Lab Delo; 1986; (3):143-5. PubMed ID: 2421080
    [No Abstract]   [Full Text] [Related]  

  • 16. Non diffusible toxic polypeptides in uraemic sera: a new group of uraemic toxins.
    Gróf J; Menyhárt J
    Acta Chir Acad Sci Hung; 1977; 18(3):283-7. PubMed ID: 605725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Middle molecules" in acute experimental uremia.
    Lutz W; Madry K; Grande G
    Acta Med Pol; 1978; 19(4):417-24. PubMed ID: 752244
    [No Abstract]   [Full Text] [Related]  

  • 18. Roles of hippurate and indoxyl sulfate in the impaired ligand binding by azotemic plasma.
    Gulyassy PF; Jarrard E; Stanfel L
    Adv Exp Med Biol; 1987; 223():55-8. PubMed ID: 3128940
    [No Abstract]   [Full Text] [Related]  

  • 19. The ultimate salt war? Uraemic toxins are all that count in dialysis patients.
    Vanholder R
    Nephrol Dial Transplant; 2012 Jan; 27(1):62-6. PubMed ID: 22287703
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases].
    Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI
    Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.